By Chris Prentice NEW YORK, June 25 (Reuters) - Denmark's Novo Nordisk, the maker of weight-loss drug Wegovy, hopes insurance will cover more U.S. users of the medication and balance direct-to-consumer sales that have driven the fast-growing market, the company's top U.S. executive said.